Lacklustre day for ISEQ

The Dublin stock exchange never stopped the losses it experienced early on in the day despite Bank of Ireland's sale of some of its UK assets and Elan's plans to relaunch its multiple sclerosis drug Tysabri.

The ISEQ was down 64.37 points to 6,654.98 by close of business this evening.

Elan and Biogen Idec are hoping to relaunch their drug Tysabri to the market as a treatment for multiple sclerosis. They said they expect to submit additional safety information to US regulators in the next few weeks. Following the announcement Elan's share prive rose 10c to €6.99.

It was announced that 10,000 customers have switched banks over the last seven months following the introduction of new forms. Most of the financials did not react well to this.

AIB slumped a massive 30c €17.40, Bank of Ireland, who also announced the sale of it's UK assets fell 10c to €12.80. Irish Life and Permanent also recorded a loss, falling 9c to €15.01.

Anglo Irish Bank bucked the trend, rising 3c to €10.98.

Ryanair, who's Cork-Dublin flights have forced Aer Arann to slash their own volume of flights, fell 9c to €6.71.